Golden Grail Beverages Announces the Acquisition of UPDC Beverages
11 déc. 2024 08h23 HE
|
Golden Grail Technology Corp.
Golden Grail Beverages Corp. (OTC: GOGY) has entered an acquisition agreement to purchase United Product Development Corporation.
Optinose to Present at the Piper Sandler 36th Annual Healthcare Conference
02 déc. 2024 15h53 HE
|
Optinose, Inc.
YARDLEY, Pa., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
Golden Grail Beverages CEO Shares Global Vision in New Interview with SmallCapVoice.com
19 nov. 2024 08h30 HE
|
Golden Grail Technology Corp.
Golden Grail Beverages (OTC: GOGY) announces the availability of a new interview with Mr. Scott Lomu, CEO of Golden Grail Beverages.
Arbutus to Present at Jefferies London Healthcare Conference
14 nov. 2024 07h30 HE
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive...
Broadwind Announces Third Quarter 2024 Results
13 nov. 2024 07h00 HE
|
Broadwind, Inc.
CICERO, Ill., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Broadwind (Nasdaq: BWEN, or the “Company”), a diversified precision manufacturer of specialized components and solutions serving global markets, today...
Optinose Reports Third Quarter 2024 Financial Results and Recent Operational Highlights
12 nov. 2024 07h00 HE
|
Optinose, Inc.
Company reports Q3 2024 XHANCE net revenue of $20.4 million, an increase of 3% compared to Q3 2023 Company reports positive inflection in new prescriptions of XHANCE starting in September Company...
Triumph Financial to Present at the Stephens Annual Investment Conference on November 19, in Nashville, Tennessee
08 nov. 2024 16h07 HE
|
Triumph Financial, Inc.
DALLAS, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Triumph Financial, Inc. (Nasdaq: TFIN) today announced that Aaron Graft, Vice Chairman and CEO, will present at the Stephens Annual Investment Conference on...
Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 13, 2024
06 nov. 2024 08h00 HE
|
Liquidia Corporation
Liquidia Corporation (LQDA) to report its third quarter 2024 financial results on November 13, 2024, via webcast at 8:30 a.m. ET
Arbutus Reports Third Quarter 2024 Financial Results and Provides Corporate Update
06 nov. 2024 07h30 HE
|
Arbutus Biopharma Corporation
Imdusiran data from IM-PROVE I and IM-PROVE II Phase 2a clinical trials to be presented at upcoming AASLD - The Liver Meeting 2024 Multiple-ascending doses of AB-101 in healthy subjects in the Phase...
Optinose Announces Reporting Date for Third Quarter 2024 Financial Results
05 nov. 2024 16h30 HE
|
Optinose, Inc.
YARDLEY, Pa., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...